| Catalog Number |
305918 |
| Medical Device Problem Code |
Device Contamination with Chemical or Other Material (2944)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
10/27/2024
|
|
Type of Reportable Event
|
Malfunction
|
|
Event or Problem Description
|
|
Material# 305918 batch# unknown it was reported that the bd safetyglide needle was coring.The following information was provided by the initial reporter: verbatim: rcc received a complaint via email.Email(s) attached.Bedside rn pulled iv lorazepam from omni, punctured rubber stopper on vial with 18g bd safetyglide needle (ref: (b)(4), and a piece of rubber from the stopper was in the 1ml medication syringe.Rn noticed the piece of rubber and notified double signing rn that dose should be wasted.Bedside rn and double signing rn wasted dose in omni and drew up another dose with a different style of needle which did not cause any pieces of rubber to enter the iv lorazepam or the medication syringe.
|
| |
|
Additional Manufacturer Narrative
|
|
Investigation summary: as no physical sample or lot number was provided for evaluation by our quality engineer team, a complete investigation could not be confirmed.Based on the limited investigation results, a cause for the reported incident could not be determined.Examination of the product involved may provide clarification as to the cause for the reported failure.Complaints received for this device and reported condition will continue to be tracked and trended.Our quality team regularly reviews the collected data for identification of emerging trends.
|
| |
|
Additional Manufacturer Narrative
|
|
Becton dickinson and company's (bd) medication delivery solutions (mds) business unit will discontinue malfunction mdr reporting for certain device failures that have not caused or contributed to deaths or serious injuries in the past two years, and where the likelihood of a death or serious injury as a result of these malfunctions is remote.This decision follows fda guidelines (medical device reporting for manufacturers guidance for industry and food and drug administration staff issued nov 8, 2016, reference section 2.15).Bd notified fda of this decision on mar 3, 2025.Fda has reviewed and responded to bd¿s notification (reference fda document # (b)(4)) on march 7, 2025.This documentation is available in bd document management system (sap) as dir 10000690801.This supplemental mdr is being filed to document that the below device failure will no longer be considered a reportable malfunction mdr for the product family below: product family: safetyglide.Device failure: needle coring.
|
| |
|
Event or Problem Description
|
|
No additional information.
|
| |
|
Search Alerts/Recalls
|